Cargando…
Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species
Candida auris, first described in 2009, has since emerged as an important, multidrug-resistant, nosocomial agent of candidemia, with large outbreaks reported worldwide and high mortality rates associated with therapeutic failure. The current study employed C. auris isolates from a variety of centers...
Autores principales: | Borman, Andrew M., Szekely, Adrien, Johnson, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990711/ https://www.ncbi.nlm.nih.gov/pubmed/27547827 http://dx.doi.org/10.1128/mSphere.00189-16 |
Ejemplares similares
-
Candida auris: An emerging pathogen “incognito”?
por: Nett, Jeniel E.
Publicado: (2019) -
NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
por: Cleare, Levi G., et al.
Publicado: (2020) -
Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model
por: Forgács, Lajos, et al.
Publicado: (2020) -
970. Emerging Pathogen Candida auris Evades Neutrophil Attack
por: Johnson, Chad, et al.
Publicado: (2018) -
Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack
por: Johnson, Chad J., et al.
Publicado: (2018)